Novel tetrahydroisoquinoline compounds of the formula:
wherein R1 is lower alkyl or phenyl-lower alkyl, R2 is alkyl or phenyl-lower alkyl, R3 is hydrogen or lower alkyl and R4 is hydrogen, lower alkyl or aralkyl, and pharmaceutically acceptable salts thereof are disclosed. Said compounds (I) and salts thereof are useful as hypotensive agent.
There is also described a process for preparation of said compounds as well as pharmaceutical compositions containing same.
式中的新型
四氢异喹啉化合物:
其中 R1 是低级烷基或
苯基低级烷基,R2 是烷基或
苯基低级烷基,R3 是
氢或低级烷基,R4 是
氢、低级烷基或芳烷基。所述化合物 (I) 及其盐类可用作降血压剂。
此外,还描述了制备上述化合物以及含有上述化合物的药物组合物的工艺。